Literature DB >> 7603161

Should factor XII assays be included in thrombophilia screening?

M Winter, M Gallimore, D W Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7603161     DOI： 10.1016/s0140-6736(95)92682-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Factor XII deficiency and recurrent sixth nerve palsy.

Authors:  A Kipioti; O C Backhouse; P M Jacobs; M R Howard
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

2.  Symptomatic combined homozygous factor XII deficiency and heterozygous factor V Leiden. luscaber@tin.it.

Authors:  A Girolami; P Simioni; L Scarano; B Girolami; P Zerbinati
Journal:  J Thromb Thrombolysis       Date:  2000-04       Impact factor: 2.300

3.  Essential thrombocytosis accompanied by coagulation factor XII deficiency: a case report.

Authors:  Yan Wang; Zunsong Wang; Hong Li; Kehong Bi; Chuansheng Zhu
Journal:  Int J Clin Exp Med       Date:  2014-10-15

Review 4.  The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and review of the literature.

Authors:  A Girolami; M L Randi; S Gavasso; A M Lombardi; F Spiezia
Journal:  J Thromb Thrombolysis       Date:  2004-04       Impact factor: 2.300
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.